微生物附著量測試市場 - 成長，趨勢及預測(2019年 - 2024年)
Bioburden Testing Market - Growth, Trends, and Forecast (2019 - 2024)
|出版商||Mordor Intelligence LLP||商品編碼||871416|
|出版日期||內容資訊||英文 114 Pages
|微生物附著量測試市場 - 成長，趨勢及預測(2019年 - 2024年) Bioburden Testing Market - Growth, Trends, and Forecast (2019 - 2024)|
|出版日期: 2019年05月01日||內容資訊: 英文 114 Pages||
Bioburden testing is a process of measuring viable microorganisms on medical devices, raw material, or package. The process helps in determining parameters for its sterilization process to ensure safety and effectiveness of medical devices. It further aids in routine monitoring of raw material, components, and assembly processes in the manufacturing process. The bioburden testing is used for assessment of cleaning processes, and packaging of products to ensure safety. Growth in the medical devices, pharmaceutical, and rising product recalls due to microbial contamination are factors that drive the growth of the world bioburden testing market.
In biotechnology and food & beverage industries the safety concerns supplements growth. The presence of bacteria on the surface can affect the industry like pharmaceutical and other industry which is directly related to the human begins. Various regulation has been made to check all the parameter of safety and cleaning in the industry or their products. For instance, in the U.S the Title 21 is the code of federal regulation that covers the drugs and food for the FDA. Many other organizations are also having the code and standard parameter for monitoring.
As per the scope of the report, Bioburden Testing is an integral part of validation and revalidation of sterilization processes, assessment of the efficiency of cleaning processes, routine monitoring of manufacturing processes, monitoring of raw materials, components or packaging, and overall environmental monitoring programs.
Consumables are Expected to Hold Largest Share of Global Bioburden Testing Market, Over the forecast period
Consumables accounted for the largest market share in the global Bioburden Testing market due to the high requirement of kits and reagents whereas the instruments are the one-time investment. The long shelf life of the kits and reagents and the repeated purchase of media, kits, and reagents are driving the adoption of the bioburden testing consumables.
North America Region Holds the Largest Market Share of Bioburden Testing Market
North America was the largest regional market in terms of revenue. Sustained growth in pharmaceutical and biotechnology industries, the rising food and medicine safety concerns in general public, and a strong trend of R&D investments in life sciences, by both industry and academia, are the primary factors driving the growth of the market. Increasing government support for pharmaceutical and biotechnology companies is also impacting the growth of the market in North America.
The Bioburden Testing Market consists of several major players. The companies are implementing certain strategic initiatives such as a merger, new product launch, acquisition and partnerships that help them in strengthening their market position. For instance, Charles River Laboratories is adopting innovative technology platform which is helping in streamline bioburden testing. Also, one of the players Merck KGaA., has the product for testing of bioburden name as EZ Fluo Rapid Detection, Ready-to-Use Culture Media for Bioburden Testing, and others.